(HealthDay)—Genomic recurrence score (RS) testing using a 21-gene assay is associated with decreased cancer care costs in real-world practice among certain patients with breast cancer who would otherwise receive standard ...
Apr 10, 2019
0
1
(HealthDay)—Hospitalized Medicare beneficiaries with vision loss experience longer mean length of stay, higher readmission rates, and higher costs during hospitalization and postdischarge, according to a study published ...
Apr 5, 2019
0
0
Three times a week, Tod Gervich injects himself with Copaxone, a prescription drug that can reduce the frequency of relapses in people who have some forms of multiple sclerosis. After more than 20 years with the disease, ...
Apr 2, 2019
0
1
(HealthDay)—Nearly one in 10 patients with end-stage renal disease (ESRD) undergoes lower-extremity amputation in their last year of life, according to a study published online Feb. 19 in the Journal of the American Society ...
Feb 21, 2019
0
1
Insurance industry cost-control measures may be worsening the nation's opioid epidemic by limiting access to a key medication that treats addiction, according to a research letter published today in the Journal of the American ...
Feb 12, 2019
0
3
Medicare patients with multiple sclerosis face skyrocketing out-of-pocket costs for therapies due to complicated insurance rules that force them to pick up an increasing share of the cost, according to new research.
Feb 4, 2019
0
15
(HealthDay)—Having a stronger heart after being hospitalized for heart failure may not translate into a better outcome, new research suggests.
Dec 18, 2018
0
2
Two-thirds of patients who visited a doctor in 2017 did not use a health portal that could help improve their health in the long run, according to a new study by the University of Michigan.
Dec 4, 2018
0
2
In a harbinger of potentially big changes for Medicare, seniors in many states will be able to get additional services such as help with chores, safety devices and respite for caregivers next year through private Medicare ...
Nov 9, 2018
0
11
The maker of an expensive cholesterol drug is slashing the list price, which should make it more affordable for patients.
Oct 24, 2018
0
0
